Three months ended June 30, |
||||||||||||
In millions of Euros | 2014 IFRS | Adjustment | 2,014.0 | 2013 IFRS | Adjustment | 2,013.0 | ||||||
non-IFRS |
non-IFRS |
|||||||||||
Cost of revenue |
(76.0) |
0.2 |
(75.8) |
(65.9) |
0.2 |
(65.7) |
||||||
Research and development | (107.6) | 3.4 | (104.2) | (97.1) | 3.9 | (93.2) | ||||||
Marketing and sales | (187.1) | 2.8 | (184.3) | (172.4) | 3.1 | (169.3) | ||||||
General and administrative | (45.6) | 2.0 | (43.6) | (39.1) | 2.1 | (37.0) | ||||||
Total share-based compensation expense | 8.4 | 9.3 |